Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-017236

Options or other derivatives

  • President and CEO acquired 179,104 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schultz Kare · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-04 Grant or award : show line 1 in the form Restricted Share Units +179,104 179,104 D
Loading xslF345X03/doc4.xml…